Brave New World (no pun!) [Two-Stage / GS Designs]
Sequential Designs and Interim Analyses
in Bioequivalence: FDA’s
Experience
Barbara M. Davit, Ph.D., J.D.
Director, Division of Bioequivalence II
Office of Generic Drugs, CDER, FDA
Mini-Symposium on Adaptive Study Designs and Assessment
Approaches for Bioequivalence
AAPS Annual Meeting
Chicago, IL
October 13-18, 2012
P.S.: No slide about Method B.

—
Dif-tor heh smusma 🖖🏼 Довге життя Україна!![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Dif-tor heh smusma 🖖🏼 Довге життя Україна!
![[image]](https://static.bebac.at/pics/Blue_and_yellow_ribbon_UA.png)
Helmut Schütz
![[image]](https://static.bebac.at/img/CC by.png)
The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Complete thread:
- Brave New World (no pun!)Helmut 2013-01-21 23:06
- Brave New World (no pun!) ElMaestro 2013-01-22 10:51